GAMMA Investing’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72K | Sell |
415
-374
| -47% | -$3.35K | ﹤0.01% | 3224 |
|
|
2025
Q1 | $5.92K | Buy |
789
+320
| +68% | +$2.4K | ﹤0.01% | 3015 |
|
|
2024
Q4 | $3.53K | Buy |
469
+124
| +36% | +$933 | ﹤0.01% | 3049 |
|
|
2024
Q3 | $2.62K | Buy |
345
+191
| +124% | +$1.45K | ﹤0.01% | 2981 |
|
|
2024
Q2 | $952 | Buy |
154
+46
| +43% | +$284 | ﹤0.01% | 3069 |
|
|
2024
Q1 | $549 | Buy |
108
+1
| +0.9% | +$5 | ﹤0.01% | 3091 |
|
|
2023
Q4 | $567 | Buy |
+107
| New | +$567 | ﹤0.01% | 2936 |
|